-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RIQnfWi3Vsp7ZVsZoeYTN+NZfQyuEIj+TXzHpHUYSEHu5PmqGlvID/Datjcb447U KH6KyRp1z2gjs2m0DoyeqQ== 0001425738-11-000004.txt : 20110211 0001425738-11-000004.hdr.sgml : 20110211 20110211145536 ACCESSION NUMBER: 0001425738-11-000004 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110211 DATE AS OF CHANGE: 20110211 EFFECTIVENESS DATE: 20110211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Group, LLC CENTRAL INDEX KEY: 0001425738 IRS NUMBER: 208592298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12776 FILM NUMBER: 11598294 BUSINESS ADDRESS: STREET 1: 100 PINE STREET, SUITE 1925 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-489-9980 MAIL ADDRESS: STREET 1: 100 PINE STREET, SUITE 1925 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 redq410.txt REDMILE GROUP, LLC 4Q 2010 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2010 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Redmile Group, LLC Address: 100 Pine Street, Suite #1925 San Francisco, CA 94111 13F File Number: 028-12776 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Jeremy Green Title: Managing Member Phone: 415-489-9980 Signature, Place, and Date of Signing: /s/ Jeremy Green San Francisco, CA February 11, 2011 Report Type (Check only one.): [ X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 43 Form 13F Information Table Value Total: $303,208 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- -------- AETNA INC NEW COM 00817Y108 3042 99700 SH Defined 99700 AFFYMAX INC COM 00826A109 4123 620000 SH Defined 620000 ALIGN TECHNOLOGY INC COM 016255101 11796 603700 SH Defined 603700 AMICUS THERAPEUTICS INC COM 03152W109 70 15000 SH Defined 15000 ANTHERA PHARMACEUTICALS INC COM 03674U102 4948 1013947 SH Defined 1013947 ARDEA BIOSCIENCES INC COM 03969P107 3692 142017 SH Defined 142017 ARIAD PHARMACEUTICALS INC COM 04033A100 8403 1647550 SH Defined 1647550 AUXILIUM PHARMACEUTICALS INC COM 05334D107 5383 255100 SH Defined 255100 BAXTER INTL INC COM 071813109 6970 137700 SH Defined 137700 BIOMARIN PHARMACEUTICAL INC COM 09061G101 9059 336400 SH Defined 336400 BIOMIMETIC THERAPEUTICS INC COM 09064X101 5828 458915 SH Defined 458915 BIOSPECIFICS TECHNOLOGIES CO COM 090931106 5547 216672 SH Defined 216672 CADENCE PHARMACEUTICALS INC COM 12738T100 1132 150000 SH Defined 150000 CONMED CORP COM 207410101 6873 260034 SH Defined 260034 CYCLACEL PHARMACEUTICALS INC COM 23254L108 1463 995140 SH Defined 995140 DYNAVAX TECHNOLOGIES CORP COM 268158102 4960 1550000 SH Defined 1550000 GENZYME CORP COM 372917104 3325 46700 SH Defined 46700 GTX INC DEL COM 40052B108 2950 1113215 SH Defined 1113215 HEARTWARE INTL INC COM 422368100 11118 126966 SH Defined 126966 HILL ROM HLDGS INC COM 431475102 8902 226105 SH Defined 226105 INCYTE CORP COM 45337C102 10915 659126 SH Defined 659126 LEMAITRE VASCULAR INC COM 525558201 2103 310696 SH Defined 310696 MAP PHARMACEUTICALS INC COM 56509R108 3595 214745 SH Defined 214745 MEDTRONIC INC COM 585055106 10756 290000 SH Defined 290000 MICROMET INC COM 59509C105 5487 675800 SH Defined 675800 NEKTAR THERAPEUTICS COM 640268108 14908 1160186 SH Defined 1160186 NXSTAGE MEDICAL INC COM 67072V103 12941 520120 SH Defined 520120 ONYX PHARMACEUTICALS INC COM 683399109 16190 439100 SH Defined 439100 ORTHOFIX INTL N V COM N6748L102 11874 409450 SH Defined 409450 PACIFIC BIOSCIENCES OF CALIF COM NEW 69404D108 8169 513472 SH Defined 513472 PROTALIX BIOTHERAPEUTICS INC COM 74365A101 6778 679200 SH Defined 679200 RAPTOR PHARMACEUTICAL CORP COM 75382F106 1966 540000 SH Defined 540000 SEQUENOM INC COM 817337405 21108 2628600 SH Defined 2628600 STRYKER CORP COM 863667101 7357 137000 SH Defined 137000 THORATEC CORP COM 885175307 10931 385992 SH Defined 385992 TOMOTHERAPY INC COM 890088107 4245 1175872 SH Defined 1175872 UNITED THERAPEUTICS CORP DEL COM 91307C102 11557 182800 SH Defined 182800 UNITEDHEALTH GROUP INC COM 91324P102 9085 251600 SH Defined 251600 VERTEX PHARMACEUTICALS INC COM 92532F100 8824 251900 SH Defined 251900 XENOPORT INC COM 98411C100 5122 601200 SH Defined 601200 YM BIOSCIENCES INC COM 984238105 2055 881900 SH Defined 881900 ZIMMER HLDGS INC COM 98956P102 5561 103600 SH Defined 103600 ZIOPHARM ONCOLOGY INC COM 98973P101 2097 450000 SH Defined 450000
-----END PRIVACY-ENHANCED MESSAGE-----